Premium
Treatment and prognosis of mature (non‐anaplastic) T‐ and NK‐cell lymphomas in childhood, adolescents, and young adults
Author(s) -
Xavier Ana C.,
Suzuki Ritsuro
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15772
Subject(s) - anaplastic large cell lymphoma , lymphoma , medicine , young adult , immunology , pediatrics
Summary Paediatric non‐Hodgkin lymphomas (pNHL) are a diverse group of malignancies characterised by nodal and/or extranodal involvement. Less common pNHL forms include those derived from mature T‐ and natural killer (NK) cells. Much of our current understanding of paediatric mature (non‐anaplastic) T/NK‐cell lymphomas with respect to pathogenesis, diagnosis and treatment is extrapolated from adult literature. At the Sixth International Symposium on Childhood, Adolescent and Young Adult Non‐Hodgkin Lymphoma, convened September 26–29, 2018 in Rotterdam, The Netherlands, some important aspects on diagnosis and outcomes of mature (non‐anaplastic) T/NK‐cell lymphoma in children and adolescents were discussed and will be reviewed in here.